BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21871940)

  • 1. Aluminium-based adjuvants should not be used as placebos in clinical trials.
    Exley C
    Vaccine; 2011 Nov; 29(50):9289. PubMed ID: 21871940
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors.
    Serrano C; Rothschild S; Villacampa G; Heinrich MC; George S; Blay JY; Sicklick JK; Schwartz GK; Rastogi S; Jones RL; Rutkowski P; Somaiah N; Navarro V; Evans D; Trent JC
    Nat Med; 2023 Nov; 29(11):2689-2692. PubMed ID: 37828359
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.
    Shaw CA; Tomljenovic L
    Immunol Res; 2013 Jul; 56(2-3):304-16. PubMed ID: 23609067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
    Tomljenovic L; Shaw CA
    Lupus; 2012 Feb; 21(2):223-30. PubMed ID: 22235057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
    Tomljenovic L; Shaw CA
    J Inorg Biochem; 2011 Nov; 105(11):1489-99. PubMed ID: 22099159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.
    Martínez-Lavín M; Amezcua-Guerra L
    Clin Rheumatol; 2017 Oct; 36(10):2169-2178. PubMed ID: 28730271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles outbreak in a fully immunized secondary-school population.
    Gustafson TL; Lievens AW; Brunell PA; Moellenberg RG; Buttery CM; Sehulster LM
    N Engl J Med; 1987 Mar; 316(13):771-4. PubMed ID: 3821823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine model of antiphospholipid syndrome induced by tetanus vaccine.
    Dimitrijević L; Živković I; Stojanović M; Petrušić V; Živančević-Simonović S
    Lupus; 2012 Feb; 21(2):195-202. PubMed ID: 22235053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.
    Zafrir Y; Agmon-Levin N; Paz Z; Shilton T; Shoenfeld Y
    Lupus; 2012 Feb; 21(2):146-52. PubMed ID: 22235045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus.
    Brinth LS; Pors K; Theibel AC; Mehlsen J
    Vaccine; 2015 May; 33(22):2602-5. PubMed ID: 25882168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.
    Colafrancesco S; Perricone C; Tomljenovic L; Shoenfeld Y
    Am J Reprod Immunol; 2013 Oct; 70(4):309-16. PubMed ID: 23902317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.
    Masson JD; Crépeaux G; Authier FJ; Exley C; Gherardi RK
    J Inorg Biochem; 2018 Apr; 181():87-95. PubMed ID: 29307441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines, adjuvants and autoimmunity.
    Guimarães LE; Baker B; Perricone C; Shoenfeld Y
    Pharmacol Res; 2015 Oct; 100():190-209. PubMed ID: 26275795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting post-vaccination autoimmunity: who might be at risk?
    Soriano A; Nesher G; Shoenfeld Y
    Pharmacol Res; 2015 Feb; 92():18-22. PubMed ID: 25277820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep.
    Luján L; Pérez M; Salazar E; Álvarez N; Gimeno M; Pinczowski P; Irusta S; Santamaría J; Insausti N; Cortés Y; Figueras L; Cuartielles I; Vila M; Fantova E; Chapullé JL
    Immunol Res; 2013 Jul; 56(2-3):317-24. PubMed ID: 23579772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
    Exley C
    Allergy Asthma Clin Immunol; 2014 Jan; 10(1):4. PubMed ID: 24444186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.
    Perricone C; Colafrancesco S; Mazor RD; Soriano A; Agmon-Levin N; Shoenfeld Y
    J Autoimmun; 2013 Dec; 47():1-16. PubMed ID: 24238833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells.
    Ohlsson L; Exley C; Darabi A; Sandén E; Siesjö P; Eriksson H
    J Inorg Biochem; 2013 Nov; 128():229-36. PubMed ID: 23992993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.
    Colafrancesco S; Agmon-Levin N; Perricone C; Shoenfeld Y
    Immunol Res; 2013 Jul; 56(2-3):200-5. PubMed ID: 23733136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following immunization with vaccines containing adjuvants.
    Cerpa-Cruz S; Paredes-Casillas P; Landeros Navarro E; Bernard-Medina AG; Martínez-Bonilla G; Gutiérrez-Ureña S
    Immunol Res; 2013 Jul; 56(2-3):299-303. PubMed ID: 23576057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.